Sucampo Seeks To Terminate Amitiza Marketing Agreement With Takeda
This article was originally published in The Pink Sheet Daily
Executive Summary
Sucampo Pharmaceuticals requests arbitration to end its partnership with Takeda, claiming the company has failed to maximize sales of the constipation drug Amitiza.